AstraZeneca reports $275 million sales of COVID shot

Muscat: Sales of AstraZeneca vaccine exceeded 270 million in the first quarter of this year.

Oman News Agency ONA said: "The drug manufacturer AstraZeneca announces that it's COVID-19 vaccine has achieved sales of $275 million in the first quarter of this year."